✦ LIBER ✦

UP-03.49: Gemcitabine plus cisplatine versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic transitional cell carcinoma of bladder

✍ Scribed by M. Arslan; B. Gunlusoy; T. Degirmenci; N. Nergiz; S. Minareci; A. Ayder

Book ID: 116947014
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 62 KB
Volume: 68
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2006.08.907

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant methotrexate, vinblastine, d

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder

✍ Ralph J. Miller Jr.; Robert R. Bahnson; Barbara Banner; Marc S. Ernstoff; Walter 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Methotrexate, vinblastine, doxorubicin a

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

✍ Han, K S; Joung, J Y; Kim, T S; Jeong, I G; Seo, H K; Chung, J; Lee, K H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Relative Efficacy of Perioperative Gemci

Relative Efficacy of Perioperative Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urothelial Carcinoma of the Bladder

✍ Olga Yeshchina; Gina M. Badalato; Matthew S. Wosnitzer; Gregory Hruby; Arindam R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Phase III comparison of methotrexate, vi

Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium

✍ Harry J. Long III; Robert A. Nelimark; Karl C. Podratz; Vera Suman; Gary L. Keen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB